Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026
Published: July 23, 2026
Duration: 12:28
In this episode of Global Economic Press, Alex Brady discusses the recent business combination between Instinct Bio and Relativity Acquisition Corporation, marking Instinct Bio's debut on the Nasdaq Stock Market under the ticker "BIOT" on July 24, 2026. This significant development positions Instinct Bio as a publicly listed life sciences company, offering United States investors a unique opportunity to engage with the transformative field of regenerative medicine and longevity. The podcast explores the implications of this milestone for the healthcare industry and the future of healthcare innovation, highlighting Instinct Bio's integrated approach to stem cell technology, in-house manufacturing, and premium consumer...